Investigadores del Cima Universidad de Navarra coordinan un estudio que confirma el papel crucial del gen FOSL1 en la aparición y progresión del colangiocarcinoma
Read moreNúria Malats from the CNIO and Ravid Straussman from the Weizmann Institute of Science in Israel will lead a project to study the microbiome of an aggressive and little-studied type of bladder can...
Read moreLa caracterización del microambiente inmunológico ha mostrado la importancia de la biología del tumor en la activación del sistema inmune y cómo la localización y la actividad de las células in...
Read moreThe researchers have discovered that USP7 inhibitors -under development by several pharmaceutical companies for the treatment of cancer- trigger a premature activation of cell cycle proteins, leadi...
Read moreThe OncoFOLLOW™ tests will help monitor disease progression in patients under treatment within the SCANDARE study
Read moreLa obesidad cada día está más presente en nuestra sociedad y siempre se debe tener en cuenta por todas las enfermedades metabólicas derivadas, pero, a partir de ahora, aún más. Los últimos hall...
Read moreSpain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
Read moreResearchers from IDIBELL Regenerative Program has discovered that this inactivation is affected in bone marrow aged stem cells.
Read moreThe companies will combine their advanced technologies to provide an individualized vaccine design for patients with no treatment options
Read moreAs an approach to personalised medicine, the work proposes the HMCES sensor of DNA damage as a target to treat some of the most aggressive types of lung tumours. The results have been published in PL...
Read moreThe Neuro-Oncology research group from IDIBELL, the Bellvitge University Hospital, and the ICO describe the clinical manifestations of brain inflammation caused by oncological therapy with immune chec...
Read moreLos investigadores han comparado el genoma germinal de 751 pacientes pediátricos con tumores sólidos con el genoma correspondiente a sus tumores y el de sus progenitores, para estimar su predisposic...
Read more